CX3CL1-Fc treatment prevents atherosclerosis in Ldlr KO mice

Authors: Matthew Riopel, Melanie Vassallo, Erik Ehinger, Jennifer Pattison, Karen Bowden, Holger Winkels, Maria Wilson, Ron de Jong, Sanjay Patel, Deepika Balakrishna, James Bilakovics, Andrea Fanjul, Artur Plonowski, Christopher J. Larson, Klaus Ley, Pedro Cabrales, Joseph L. Witztum, Jerrold M. Olefsky, Yun Sok Lee

Source: Molecular Metabolism, Vol 20, Iss , Pp 89-101 (2019)

Subject Terms: Internal medicine, RC31-1245

File Description: electronic resource

Relation: http://www.sciencedirect.com/science/article/pii/S2212877818306197; https://doaj.org/toc/2212-8778

Access URL: https://doaj.org/article/9aa1e09a965d493391f4ff36b42d349a

Bicyclic heterocycles for the treatment of diabetes and other diseases

Heterocyclic amide derivatives for the treatment of diabetes and other diseases

Substituted dihydronaphthalene and isochroman compounds for the treatment of metabolic disorders, cancer and other diseases

Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases

This result is not displayed to guests.
Login for full access.